Info for research participants

"The most important breakthroughs in clinical medicine have been achieved by research studies. Rationally designed studies have yielded powerful empirical evidence, which, in turn, has led to marked improvements in the diagnosis and treatment of many different diseases."¹

Clinical research helps to improve medical care
Patient safety and confidentiality are our highest priorities. Each study is conducted according to a carefully designed study protocol, which specifies all details pertaining to the study. Beyond these protocols, patient safety and confidentiality are ensured by independent ethics committees of the universities and medical associations involved in the studies – "ethics committees (sometimes known as ethical review boards or institutional review boards, IRB) are groups of experts evaluating the scientific and ethical merit of research studies. They are typically formed by physicians, natural scientists, attorneys, and lay persons".² These committees have the task of reviewing the protocol of each planned study and then either allowing the study to proceed or not.

deprexis is continuously being updated and evaluated scientifically by various national and international universities and clinical project partners. The success of therapy research always requires the support of the people affected by the respective condition. Every study and, therefore, every study participant plays an important part in the development of new diagnostic and treatment methods. We are very grateful to each person who is willing to participate in deprexis-related research.

Frequently asked questions about deprexis research

• Does it cost anything to participate in the research? No. All study participants receive access to deprexis for free. There are never any costs incurred by study participation, neither during the study nor afterwards. Also, there is no "automatic subscription" clause, according to which study participants would have to pay later.
• For how long can the program be used? Typically, deprexis can be used for three months by each participant. However, this duration can vary from study to study.
• Do research participants have to cancel their membership after the study is over? No. No cancellation is required. Every deprexis license automatically becomes inactive after 3 months.
• Can anyone participate in deprexis research? Depending on the goals of each particular study, there are typically certain inclusion and exclusion criteria that must be met by potential study participants. This means that there are specific characteristics that may or may not make you eligible for participation, depending on the study’s objectives.
• What about data safety and confidentiality? Personal data are handled strictly confidentially and are never passed on to third parties. Data storage is handled in line with the data safety and protection laws and regulations as specified in German federal law (the so-called Bundesdatenschutzgesetz, BDSG) as well as other relevant laws and regulations, depending on each study’s setting and circumstances. The specific details pertaining to data safety and confidentiality will be provided to participants by the investigators prior to the start of each study.
• How long does a study take? The durations of studies differ depending on each study’s unique design and research questions.

If you interested in participating in deprexis research but are not yet involved in any ongoing study by one of our research partners, please feel free to get in touch with us. We would be happy to include you in our participant registry:

info@deprexis.com
 
We will be happy to contact you as soon as an opportunity for research participation becomes available.

¹Wink (2010). Klinische Studienrichtig darstellen, Seite 5, Schattauer GmbH
²Herschel (2010). Das Klifo-Buch: Praxisbuch Klinische Forschung, Seite 6, Schattauer GmbH